Terry Fry, MD
Clinical Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation
- Professor of Pediatrics, Hematology and Immunology
Director of Cancer Immunotherapy
School of Medicine,
Co-Director, Human Immunology and Immunotherapy Initiative
School of Medicine,
Shalabi H, Yuan CM, Kulshreshtha A, Dulau-Florea A, Salem D, Gupta GK, Roth M, Filie AC, Yates B, Delbrook C, Derdak J, Mackall CL, Lee DW, Fry TJ, Wayne AS, Stetler-Stevenson M, Shah NN. Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement. Pediatr Blood Cancer. 2020 Jan 25;:e28149. [Epub ahead of print] PubMed PMID: 31981407
Shah NN, Qin H, Yates B, Su L, Shalabi H, Raffeld M, Ahlman MA, Stetler-Stevenson M, Yuan C, Guo S, Liu S, Hughes SH, Fry TJ, Wu X. Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy. Blood Adv. 2019 Aug 13;3(15):2317-2322. PubMed PMID: 31387880
Fry TJ. Introduction: Immunological Reviews volume 290. Immunol Rev. 2019 Jul;290(1):4-5. PubMed PMID: 31355490
Walsh Z, Ross S, Fry TJ. Multi-Specific CAR Targeting to Prevent Antigen Escape. Curr Hematol Malig Rep. 2019 Oct;14(5):451-459. PubMed PMID: 31332617
Panch SR, Srivastava SK, Elavia N, McManus A, Liu S, Jin P, Highfill SL, Li X, Dagur P, Kochenderfer JN, Fry TJ, Mackall CL, Lee D, Shah NN, Stroncek DF. Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics. Mol Ther. 2019 Jul 3;27(7):1275-1285. PubMed PMID: 31178392
- Pediatric Hematology / Oncology, Board Certification
My primary clinical and research interest is immunotherapy for pediatric leukemia.
I view my relationship with patients and families as a partnership in which we make what are often complicated decisions together. This is only possible through open discussion and sharing of information. This partnership is one of the great privileges of being a physician.